Pliva, Others Escape Generic Reglan Suit Due To Mensing

Law360, New York (August 29, 2012, 3:23 PM EDT) -- Pliva Inc. and two other generic-drug makers have won the dismissal of a suit in Louisiana federal court that claimed a woman's movement disorder was caused by generic Reglan, ruling design defect and other allegations are preempted by the U.S. Supreme Court decision in Pliva Inc. v. Mensing.

Plaintiff Mildred Jacobsen claimed metoclopramide manufactured by Pliva, Actavis Inc., an Actavis subsidiary, and Northstar Rx LLC caused her tardive dyskinesia. Metaclopramide is the generic form of the diabetes medication Reglan.

The companies failed to adequately warn of...
To view the full article, register now.